Finance
The company will use the funds to augment key content partnerships.
Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.
Managing AI agents and prompt engineering is not like standard software engineering, and no one has really figured out how to do it at scale reliably yet, says Dr. Lukasz Kowalczyk, a gastroenterologist and CEO of Soothien HealthTech Advisory.
Proceeds will go to settling debts and focusing on its business in the United States.
Mark Newman, founder and CEO of Nomi Health, recommends driving accountability on fully automating payments for primary care visits to providers. He says there is no reason why they should be delayed or slow.
The acquisition, part of a strategic partnership to accelerate Arcadia's growth and innovation, marks an exit for former investor Peloton Equity.
Different types of artificial intelligence help mirror clinical judgement and deliver real-time insights across the areas of the mid-revenue cycle, specifically utilization management, clinical documentation and coding, says William Chan, cofounder and CEO of Iodine Software.
Christopher McGhee says that, along with the acquisition, Current Health will have a "return to scrappiness and that startup spirit."
HIMSS25
Nicole Rogas, RevSpring president, says health systems can improve the billing experience and collect more revenue by using AI and data analytics to create personalized messages delivered via patients' preferred contact methods.